Why PROCEPT BioRobotics Corporation’s (PRCT) Stock Is Up 6.73%
As of Wednesday, November 18, PROCEPT BioRobotics Corporation’s PRCT share price has surged by 6.73%, which has investors questioning if this is right time to sell.Tudor Pop
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Tudor Pop
Rosalio Madrigal
Michael Rose
Tudor Pop
Jenna Brashear
| Share Statistics | PRCT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,421.1 | $363.7 | 51% |
|
| Shares Out (Mil) | 57.3 | 41.1 | 50% |
|
| Institutional Ownership | 97.1% | 82.7% | 72% |
|
| Float (Mil) | 56.0 | 36.7 | 49% |
|
| Beta | 0.84 | 0.89 | 49% |
|
| Avg Daily Volume (000s) | 1,439 | 326 | 75% |
|
| Price Change (52-week) |
(11.6%) | 54.6% | 44% |
|
| Growth | PRCT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 109.1% | 11.8% | 99% |
|
| Net Income (5yr) | (12.5%) | (5.8%) | 27% |
|
| EPS (5yr) | 34.7% | 10.6% | 85 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.5%) | (15.6%) | 48% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 11 | 12 | 12 | |
| Current EPS | ($0.227) | ($1.723) | ($1.244) | |
| Month Ago EPS | ($0.255) | ($1.682) | ($1.172) | |
| # Rev Up | 0 | 0 | 1 | |
| # Rev Down | 1 | 1 | 0 | |
| Three Months Ago EPS | ($0.254) | ($1.680) | ($1.153) | |
| Year/Year Chg | (51.0%) | 0.1% | (48.8%) | |
| Financials | PRCT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $352 | $123 | 37% |
|
| Net Income (TTM) (Mil) | ($115) | ($9) | 10% |
|
| EPS (TTM) | ($2.024) | ($0.300) | 14% |
|
| Operating Cash Flow (TTM) (Mil) | ($77) | ($1) | 7% |
|
| Net Cash Flow (TTM) (Mil) | ($76) | $2 | 18% |
|
| Long-Term Debt (Q1) (Mil) | $74 | $21 | 42% |
|
| Enterprise Value (Q1) (Mil) | $1,045 | $381 | 42% |
|
| Valuation | PRCT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.31 | 2.41 | 79% |
|
| P/E | na | 25.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.3 | na |
|
| Ratios | PRCT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 63.7% | 59.5% | 76% |
|
| Net Margin | (32.6%) | (5.0%) | 14% |
|
| ROA | (23.3%) | (10.4%) | 18% |
|
| ROE | (32.4%) | (8.4%) | 19% |
|
| Liabilities to Assets | 30.6% | 45.8% | 22% |
|
| F-Score | 3 | 4 | 18% |
|
PROCEPT BioRobotics Corporation did not pass any screens on 11/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors